The operating team
- Hipu Diagnostic Centre begins COVID risk preventive test
By Pradeep Kumar
NAHARLAGUN, Oct 17: Three lower (uterine) segment caesarean section operations have been conducted successfully on three COVID-19 positive expecting mothers since Friday at Pasighat-based Bakin Pertin General Hospital (BPGH), Health service joint director-cum-BPGH in-charge Dr. Dukhum Raina told this daily on late Saturday.
One case each was referred from Yingkiong, Aalo and Talem while the babies and mothers have been doing well, he said, and lauded gynaeocologist Dr Bipin Karlo, anaethetist Dr Gangam Dai, senior paediatrician nursing officer, operation theatre boy and all frontline COVID warriors for the success against all odds and shortcomings. The Talem mother, a resident of Jarku, is a staff of district court here, he said.
Meanwhile, a plasma bank was installed at BPGH recently and ophthalmologist Dr Beauty Borang is in-charge. However, its nitty-gritty is still in process. However, when informed, Health & Family Welfare Minister Alo Libang assured all help to make it functional soon.
The first plasma bank of Arunachal Pradesh was inaugurated in Tomo Riba Institute of Health and Medical Sciences (TRIMHS) here by H&FW Minister Alo Libang here on Thursday last.
Confirming the information, Health Service director Dr Moromor Lego, when contacted, said that he had taken the initiative for both hospitals.
Meanwhile, Hipu Diagnostic Centre here inked a record by starting COVID-19 risk preventive test at low cost but first in the state, its management informed.
It may be mentioned here that Assam Medical College was first in North East India to open plasma bank on July 3 last followed Gauhati Medical College & Hospital on July 9 though Govt Medical College Hospital in New Delhi’s Manjeri was first in India to set up plasma bank to successfully administered plasma therapy on critically-ill COVID-19 patients to save their lives on June 9 last.
Plasma therapy is a medical procedure that uses the blood of a recovered patient to create antibodies on those infected individuals. Medically known as convalescent plasma therapy, this treatment uses antibodies (a type of protein i.e produced by plasma) found in the blood taken from a recovered Covid-19 patient. It is then used to treat those with severe SARS-CoV-2 infection to aid recovery. Currently, it has shown positive results in Delhi and Mumbai where COVID cases are spiking high. It has also proven to improve the ability of a person to recover from the disease. However, in-depth research is continuing to prove its full efficacy in different patient types, according to medical experts.